Search Results - "Saluja, Sumedha"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma by Mishra, Nitesh, Kumar, Sanjeev, Singh, Swarandeep, Bansal, Tanu, Jain, Nishkarsh, Saluja, Sumedha, Kumar, Rajesh, Bhattacharyya, Sankar, Palanichamy, Jayanth Kumar, Mir, Riyaz Ahmad, Sinha, Subrata, Luthra, Kalpana

    Published in PLoS pathogens (01-09-2021)
    “…Cross-reactive epitopes (CREs) are similar epitopes on viruses that are recognized or neutralized by same antibodies. The S protein of SARS-CoV-2, similar to…”
    Get full text
    Journal Article
  2. 2

    Inflammation as a driver of hematological malignancies by Saluja, Sumedha, Bansal, Ishu, Bhardwaj, Ruchi, Beg, Mohammad Sabique, Palanichamy, Jayanth Kumar

    Published in Frontiers in oncology (20-03-2024)
    “…Hematopoiesis is a tightly regulated process that produces all adult blood cells and immune cells from multipotent hematopoietic stem cells (HSCs). HSCs…”
    Get full text
    Journal Article
  3. 3

    Mosaic variegated aneuploidy syndrome 2 with biallelic novel CEP57 splice site variation in Indian siblings: Expanding the clinical and molecular spectrum by Langeh, Nitika, Saluja, Sumedha, Ethayathulla, Abdul Samath, Jana, Manisha, Shukla, Rashmi, Palanichamy, Jayanth Kumar, Gupta, Neerja

    Published in Clinical genetics (01-04-2023)
    “…Mosaic variegated aneuploidy syndrome 2 (MVA2) (MIM# 614114) is a rare autosomal recessive condition caused by biallelic loss of function variants in the CEP57…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Metformin Induces Modulation of Differentiation Markers in Colorectal Cancer Cell Lines by Kaur, Amar Preet, Bhattacharya, Aditi, Manhas, Janvie, Saluja, Sumedha, Khanna, Paras, Dey, Devanjan, Sen, Sudip

    Published in Indian journal of clinical biochemistry (24-05-2022)
    “…Metformin is an anti-diabetic drug that has anti-carcinogenic activity. Its anticancer activity may be attributable to its ability to induce differentiation in…”
    Get full text
    Journal Article
  7. 7

    A patient with POLA1 splice variant expands the yet evolving phenotype of Van Esch O'Driscoll syndrome by Endrakanti, Mounika, Saluja, Sumedha, Ethayathulla, Abdul S., Sapra, Savita, Dalal, Ashwin, Palanichamy, Jayanth Kumar, Gupta, Neerja

    Published in European journal of medical genetics (01-08-2021)
    “…Van Esch-O’Driscoll syndrome (VEODS) is a rare cause of syndromic X-linked intellectual disability characterised by short stature, microcephaly, variable…”
    Get full text
    Journal Article
  8. 8

    Comparing Migratory and Mechanical Properties of Human Bone Marrow-Derived Mesenchymal Stem Cells with Colon Cancer Cells In Vitro by Bhattacharya, Aditi, Saluja, Sumedha, Managuli, Vishwanath, Agrawal, Sandeep, Dey, Devanjan, Garg, Bhavuk, Ansari, Mohammed Tahir, Roy, Sitikantha, Sen, Sudip

    Published in Journal of gastrointestinal cancer (01-09-2021)
    “…Background Colon cancer cells can migrate and metastasize by undergoing epithelial-to-mesenchymal transition (EMT). Mesenchymal stem cells (MSCs) are…”
    Get full text
    Journal Article
  9. 9

    Comparing Mechanical Stiffness, EMT/MET and Stemness in Colon Carcinoma Cell Lines and Human Bone Marrow Derived Mesenchymal Stem Cells by Saluja, Sumedha, Bhattacharya, Aditi, Khera, Nupur, Agrawal, Sandeep K, Ansari, Mohd. Tahir, Managuli, Vishwanath, Roy, Sitikantha, Sen, Sudip

    Published in Indian journal of clinical biochemistry (24-05-2022)
    “…Epithelial to mesenchymal transition (EMT) and mesenchymal to epithelial transition (MET) are two biological processes that are known to play an important role…”
    Get full text
    Journal Article